» Articles » PMID: 8197409

Neuropsychological Risk Indicators for Schizophrenia: a Review of Family Studies

Overview
Journal Schizophr Bull
Specialty Psychiatry
Date 1994 Jan 1
PMID 8197409
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

We reviewed potential neuropsychological risk indicators for schizophrenia by addressing two broad questions about neuropsychological performance in biological relatives of schizophrenia patients: (1) Is there evidence of deficits, and, if so, (2) are those deficits similar to deficits found in schizophrenia patients themselves? There has not yet been adequate validation of most neuropsychological risk indicators, but promising leads have emerged from studies of relatives of persons with schizophrenia. The strongest evidence of impairment in relatives was in sustained attention, perceptual-motor speed, and concept formation and abstraction; to a slightly lesser extent, mental control/encoding (primarily with distraction) was implicated as well. Impairments in verbal memory and verbal fluency were also found, although these have been less well studied. The pattern of deficits paralleled that found in schizophrenia patients, thus suggesting dysfunction in prefrontal, temporal-limbic, and attentional systems. Findings were similar for children and adult relatives of schizophrenia patients. It is suggested that future studies (1) emphasize comprehensive test batteries, (2) develop composite neuropsychological measures, (3) use profile and deviant-responder analyses, (4) include psychiatric comparison groups, and (5) integrate neuropsychological assessments with brain imaging techniques.

Citing Articles

Exploring the Genetic Landscape of Mild Behavioral Impairment as an Early Marker of Cognitive Decline: An Updated Review Focusing on Alzheimer's Disease.

Angelopoulou E, Koros C, Hatzimanolis A, Stefanis L, Scarmeas N, Papageorgiou S Int J Mol Sci. 2024; 25(5).

PMID: 38473892 PMC: 10931648. DOI: 10.3390/ijms25052645.


Transcriptome-wide and stratified genomic structural equation modeling identify neurobiological pathways shared across diverse cognitive traits.

Grotzinger A, de la Fuente J, Davies G, Nivard M, Tucker-Drob E Nat Commun. 2022; 13(1):6280.

PMID: 36271044 PMC: 9586980. DOI: 10.1038/s41467-022-33724-9.


Verbal learning deficits associated with increased anticholinergic burden are attenuated with targeted cognitive training in treatment refractory schizophrenia patients.

Joshi Y, Thomas M, Hochberger W, Bismark A, Treichler E, Molina J Schizophr Res. 2019; 208:384-389.

PMID: 30738698 PMC: 8215853. DOI: 10.1016/j.schres.2019.01.016.


Development of a Boston Treatment Program for Youth at Clinical High Risk for Psychosis: Center for Early Detection, Assessment, and Response to Risk (CEDAR).

Friedman-Yakoobian M, West M, Woodberry K, ODonovan K, Zimmet S, Gnong-Granato A Harv Rev Psychiatry. 2018; 26(5):274-286.

PMID: 30188339 PMC: 6130908. DOI: 10.1097/HRP.0000000000000181.


Assessment of Neurocognitive Functions in 7-Year-Old Children at Familial High Risk for Schizophrenia or Bipolar Disorder: The Danish High Risk and Resilience Study VIA 7.

Hemager N, Plessen K, Thorup A, Christiani C, Ellersgaard D, Spang K JAMA Psychiatry. 2018; 75(8):844-852.

PMID: 29926086 PMC: 6143091. DOI: 10.1001/jamapsychiatry.2018.1415.